Related Experiment Video
Updated: May 3, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
What We Know About Diet, Genes, and Dyslipidemia: Is There Potential for Translation?
Toni I Pollin1, Michael Quartuccio2
1Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland ; Program in Genetics and Genomic Medicine, Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland.
Insights
Genetics influence dyslipidemia, a risk factor for coronary artery disease (CAD). Research is ongoing to link genetic variations to dietary responses for personalized CAD prevention strategies.
Area of Science:
- Cardiovascular Science
- Nutrigenetics
- Medical Genetics
Background:
- Cardiovascular disease (CVD), especially coronary artery disease (CAD), is a primary cause of mortality in the US.
- Dyslipidemia, characterized by abnormal lipid levels (e.g., high LDL-C, triglycerides; low HDL-C), is a significant CAD risk factor.
- Both genetic and lifestyle factors, particularly diet, influence dyslipidemia development.
Purpose of the Study:
- To explore the genetic underpinnings of dyslipidemia.
- To investigate how genetic differences impact lipid responses to dietary interventions.
- To assess the potential for personalized dietary recommendations for dyslipidemia management.
Main Methods:
- Review of recent advancements in understanding the genetic basis of dyslipidemia.
- Analysis of existing data on genetic variations and their association with lipid profiles.
- Examination of current dietary recommendations for monogenic lipid disorders.
Main Results:
- Significant progress has been made in identifying genes associated with dyslipidemia.
- Some monogenic conditions, like familial hypercholesterolemia, have established dietary guidelines.
- Emerging associations for polygenic dyslipidemia require further investigation in large-scale dietary studies.
Conclusions:
- Understanding genetic influences on dyslipidemia is crucial for CAD prevention.
- Personalized dietary recommendations based on genetic profiles show promise but need more research.
- Large dietary intervention studies incorporating genetic data are necessary for clinical translation.
Abstract:
Cardiovascular disease, particularly coronary artery disease (CAD), is the leading cause of death in the United States. Dyslipidemia, including elevated low density lipoprotein cholesterol (LDL-C) and triglyceride (TG) levels and low high density lipoprotein cholesterol (HDL-C), is a well-established risk factor for CAD and is influenced by both genetic and lifestyle factors, including the diet and dietary fat in particular. Major strides in elucidating the genetic basis for dyslipidemia have been made in recent years, and the quest to clarify how genetic differences influence lipid response to dietary intervention continues. Some monogenic conditions such as famililal hypercholesterolemia and sitosterolemia already have customized dietary recommendations. Some promising associations have emerged for more polygenic dyslipidemia, but further studies are needed in large dietary intervention studies capturing increasing amounts of explainable genetic variation before recommendations can be made for clinical translation.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management
Pharmacogenetics of Drug Metabolism: Overview
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

